Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.

Perides G, Noring R, Klempner MS.

Biochem Biophys Res Commun. 1996 Feb 27;219(3):690-5.

PMID:
8645243
3.

Matrix metalloproteinases and cellular fibrinolytic activity.

Lijnen HR.

Biochemistry (Mosc). 2002 Jan;67(1):92-8. Review.

4.

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi.

Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, Rogers RA.

J Infect Dis. 1995 May;171(5):1258-65.

PMID:
7751701
5.

Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species.

Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA.

J Infect Dis. 1996 Jul;174(1):97-104.

PMID:
8656020
6.

The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.

Robbie LA, Booth NA, Croll AM, Bennett B.

Thromb Haemost. 1993 Aug 2;70(2):301-6.

PMID:
8236139
7.

Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.

Planus E, Barlovatz-Meimon G, Rogers RA, Bonavaud S, Ingber DE, Wang N.

J Cell Sci. 1997 May;110 ( Pt 9):1091-8.

8.

Mechanisms of physiological fibrinolysis.

Lijnen HR, Collen D.

Baillieres Clin Haematol. 1995 Jun;8(2):277-90. Review.

PMID:
7549063
9.

Evidence for an active fibrinolytic system in normal human bone marrow.

McWilliam NA, Robbie LA, Barelle CJ, Adey G, Prasad S, Bennett B, Booth NA.

Br J Haematol. 1996 Apr;93(1):170-6.

PMID:
8611456
10.

Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.

McWilliam N, Robbie L, Booth N, Bennett B.

Br J Haematol. 1998 Jun;101(4):626-31.

PMID:
9674732
11.

Elements of the fibrinolytic system.

Lijnen HR.

Ann N Y Acad Sci. 2001;936:226-36. Review.

PMID:
11460480
15.

Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.

Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.

Med Sci Monit. 2000 Jul-Aug;6(4):684-91.

16.

The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

Fuchs H, Wallich R, Simon MM, Kramer MD.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12594-8.

17.

Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.

Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.

Placenta. 2000 Mar-Apr;21(2-3):184-93.

PMID:
10736241
19.

The fibrinolytic system in human ascites.

Buø L, Karlsrud TS, Dyrhaug G, Bell H, Engström L, Johansen HT, Aasen AO.

Scand J Gastroenterol. 1995 Nov;30(11):1101-7.

PMID:
8578171
20.

Supplemental Content

Support Center